| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Strategic Planning Process |
|
Main Subject - Strategic Planning Process
In this article I will discuss complexity theory and complexity science. We will also look in to the positive and negative sides of the strategic planning process from different points of views. There is a new scienti According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product fic renaissance in the making. It will usher in
new industries, alter how businesses compete, and change how companies
are managed said Richard T. Pascale. He was referring to
complexity science or complexity theory ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in . Complexity theory deals
with systems that show complex structures in time or space, often
hiding simple, deterministic rules. This theory contends that once
these rules are found, it will be possible to make effec lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. tive
predictions and even to effectuate control of the apparent complexity.
Complexity theory, or, to be more precise, the
science of complexity, is the study of emergent order in what are
otherwise very disorderl here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe y systems. A recent paper by Davenport in the MIT Sloan Management Review bemoans the lack of a Frederick Taylor or Henry Ford for knowledge workers. Organisations, according to Taylor, are like machines; people ar d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro like cogs in those machines. Processes can be
stripped down and streamlined for greater efficiency. The best
management, said Taylor, is a true science, resting upon clearly
defined laws, rules and principles. Henr ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc y Ford took
this line of thinking and applied it to the manufacture of cars,
breaking down the industrial process into a series of repetitive tasks
performed by semi-skilled but well-paid employees, working beside a easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
slow-moving production line. In this way, Frederick Taylor’s ideas
came to underpin many of the ways of doing things which gave rise to
the new industrial age at the start of the 20th century.
Natural science in nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically the meantime has moved on. The deterministic,
closed system world of Newtonian physics has been changed forever.
Complexity theory views the world in terms of systems; not the linear,
mechanistic systems of classica and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ l physics, but complex, non-linear,
highly interactive systems complex adaptive systems in the
language of complexity. Complexity provides a rich vein for new
thinking on leadership and management. Perhaps Davenpor ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi is
wrong. Perhaps there is a new science which is highly applicable to
the leadership and management of professionals and other knowledge
workers. Businesses are complex adaptive systems, living companies accordin ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a g
to De Geus; people are people, not cogs in a machine. While
this is true of all businesses, indeed all organisations, somehow it
is particularly true of professional services firms, in which
traditional capital ( dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod plant and machinery, etc) is minimal, and human
capital (people, their behaviour, practices, knowledge, etc) is
dominant. Management guided by the principles of
complexity science constitutes a style that is very di cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin fferent from the
management model based on the ideas of Frederick Taylor. The type of
leadership required is very different too. Like traditional theory, complexity theory also concerns itself with processes and ho tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen w these influence
employee behaviour. The concept that procedures may be designed to
motivate is arguable from a contemporary social science perspective.
For e.g Herzberg’s hygiene factors, stated simple, that a pro t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel edure
as a hygiene factor does not motivate. In
terms of complexity as a dynamic system, Locke’s theory (notes that
based on his values/agent/event factors, procedures do in fact
motivate) offers both negative and ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust positive feedback loops, providing
non-linear causality and the possibility of internally generated
cyclical behaviors and non-equilibrium. The view of organizations as complex adaptive systems suggests that organiz y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ations gather
information about their surroundings, themselves and their own
behavior and then use this information for adapting to and coevolving
with their environments. From the view of complexity
theory organiz . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ations in which there are a large number of ties or
connections, widely distributed, are more capable of variety in their
behavior which in turn leads to adaptability. According to Weick, without such variety organiz elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ations will miss
important data points, will oversimplify their view of what is
happening in the environment, and will generally be unable to respond
to the high levels of variation among elements in the environment tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Discover How To Turn Your Real Estate Business Into A Cash Machine - Using Other Peoples Money
|